First-line agents in patients with no evidence of structural heart disease include flecainide, propafenone and sotalol. Whereas amiodarone and dofetilide are considered as alternative agents.
Antiarrhythmic drugs are the drugs that are used to control heart rate and mainly include beta-blockers. Along with it anticoagulant or antiplatelet therapy [warfarin (a “blood thinner”) or aspirin] is used which helps to reduce the risk of blood clots and stroke.
The main trigger factors include stress, fatigue, and alcohol use.